Arkolith/Insider Trading/OCUL/Form 4

Heier Jeffrey S.

Chief Scientific OfficerOCULAR THERAPEUTIX, INC (OCUL) · full profile →Form 4 · filed Oct 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$116K
Net Open-Market Flow
-$116K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 2, 2025Sell(S)11K$11.04$116K249K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-097163) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML